treatment with the fibrinolytic inhibitor , epsilon-aminocaproic acid , along with heparin resulted in prompt cessation of bleeding , reversal of laboratory evidence of fibrinolysis , and a decreased need for blood product support .
C0000608
epsilon-aminocaproic acid
C0019080
bleeding